You’ve been on compounded semaglutide for three or four weeks. Your appetite is down. But the scale has barely moved. Maybe it has even gone up. The question that brought you here, asked at 9 PM on a Tuesday, is whether something is broken.
For most people searching this, the honest answer is no. You are likely still on a starter dose of 0.25mg or 0.5mg. That is well below the dose used in the trials that proved weight loss works. The medication is starting to work. That is why your appetite is down. But it is not yet at the dose that drives real weight loss for the average person. The right move is rarely “try harder.” It is almost always “message the Sunlight care team about your dose.”
Below: what is normal in the first 12 weeks, the eight real reasons people stall on compounded semaglutide, and a short plan for this week.
Key takeaways
- The standard semaglutide dose ladder steps from 0.25mg to 2.4mg over about 16 to 17 weeks. The first two steps are sub-therapeutic by design — meaning they are intentionally below the dose shown to drive weight loss in clinical trials.
- Most people in the published trials of FDA-approved semaglutide did not hit real weight loss until weeks 8 to 16. Being frustrated at week 4 is normal, not failure.
- About 10 to 15 percent of people do not respond well even at the full dose. If that is you, the conversation shifts from “wait” to evaluating a medication switch.
- For Sunlight patients, the right next step is the Sunlight care team through the patient portal. A licensed clinician can review your dose and adjust your plan.
What's normal in the first 12 weeks on semaglutide
The most common reason patients write the Sunlight care team is this. They are somewhere between week 3 and week 8, on 0.25mg or 0.5mg, expecting trial-level results. The math is not there yet.
Here is the standard semaglutide dose ladder a licensed clinician sets for most new patients:
| Weeks | Dose |
| 1 to 4 | 0.25mg weekly |
| 5 to 8 | 0.5mg weekly |
| 9 to 12 | 1.0mg weekly |
| 13 to 16 | 1.7mg weekly |
| 17 onward | 2.4mg weekly (maintenance) |
The starting dose, 0.25mg, is roughly one-tenth of the 2.4mg maintenance dose. The slow climb is on purpose. It lets the side effects (nausea, constipation, fatigue) settle. That way most people can stay on the medication long enough to reach a dose that actually moves the scale.
In the STEP-1 trial of FDA-approved semaglutide (2.4mg weekly), the average weight loss at week 20 was about 6 percent of body weight. By week 68, it climbed to about 14.9 percent for the average person (Wilding et al., NEJM 2021). These numbers assume trial-level adherence and the protocol’s dose schedule. Real-world results are often lower than the trial average. The week-20 number is the one to anchor on. Even at the full dose, most participants in the trial didn’t reach double-digit weight loss until after the six-month mark.
For Sunlight patients: a licensed clinician sets your own dose schedule. The Sunlight care team can adjust it if you are not tolerating a step, or if your response looks slower than expected. If you are at week 4 on 0.25mg, you are not behind. You are exactly where the protocol puts you.
8 reasons you might not be losing weight on semaglutide
This list is ordered by how often each cause actually drives a slow start, not alphabetically and not by how guilty it makes you feel. For most people in the first 12 weeks, the answer is reason #1 or #2. The rest matter later, or in special cases.
1. You are still on a starter dose
This is the most important reason. It goes unmentioned on most pages you will find. The first two steps of the ladder (0.25mg and 0.5mg) sit below the dose used in the trials. Many people feel real appetite suppression on 0.25mg but see little movement on the scale. That feels off, but it is not. Appetite suppression at the starting dose means the medication is starting to work. Scale movement happens at the higher doses (1.0mg and above), where the medication is working at full strength.
If you are under 12 weeks in and below 1.0mg, the published data says wait, not panic. If side effects are okay, the Sunlight care team can review whether your step-up timing fits you. A licensed clinician can adjust your plan. Changing the dose on your own, up or down, is not safe and is not covered under the program.
2. You have not given it enough time
Closely related to dose, but not the same thing. Even at the right dose, semaglutide is a slow medication. Most people in the trials did not hit real weight loss until somewhere between week 8 and week 16. The rough goals from the trials look like this: about 5 percent of body weight by month 3 to 4, 10 percent by month 6, and 15 percent at month 12 to 18 for the average person.
The math gets clearer with a real example. If you weigh 220 pounds, 5 percent at month 3 is 11 pounds. That works out to under a pound a week through the slow dose climb. That is normal. It is not failure. Most marketing copy makes it sound like overnight transformation. The trial data does not.
A reasonable check-in: if you are at month 4, on 1.0mg or higher, and you have lost less than 2 to 3 percent of body weight, that is the right moment to ask the Sunlight care team to take a closer look. Before then, the answer is usually time.
3. Semaglutide is working, but your diet has not shifted
Semaglutide reduces appetite. It quiets food noise. It does not override what you eat when food is in front of you. If you are still hitting your usual daily calories, even on a smaller appetite, the scale will stall.
People who plateau here usually say the same thing: “I am not as hungry, but I still eat my normal meals out of habit.” The fix is rarely “cut carbs” or “go keto.” It is checking whether you are actually eating less than you were two months ago. Semaglutide creates the opportunity for a deficit — it doesn’t guarantee one.
According to the Mayo Clinic, hitting 25 to 35 grams of protein per meal helps protect muscle during weight loss. That keeps your resting metabolism higher and protects long-term progress.
4. You are sleeping less than 7 hours a night
According to Harvard Health Publishing, sleeping less than 7 hours disrupts leptin and ghrelin. Those are the hormones that signal hunger and fullness. Short sleep can blunt the weight-loss response to almost any treatment, including semaglutide. The effect is real biology, not lifestyle preaching.
Two practical fixes: keep a steady bedtime, even on weekends, and cut alcohol on weeknights. Alcohol breaks up sleep even when total hours stay the same. That is why a “full night” after a few drinks can still leave you hungrier the next morning.
5. Chronic stress is keeping cortisol high
Chronic stress keeps cortisol up. That promotes belly fat storage and can blunt the response to weight-loss treatments. This is real biology, not woo. The hard part is that “lower your stress” is not useful advice.
What is useful: pick one stress source you can act on this week. A hard conversation you keep avoiding. A workload that needs to be renegotiated. A bedtime that keeps you wired late. Do something concrete about that one thing. Supplements, adaptogens, and biohacks are not part of the Sunlight protocol and are not reviewed by the clinical team.
6. A medication you are on is blunting the response
Several types of medications can cause weight gain or blunt your response to a weight-loss medication. The most common: corticosteroids like prednisone, some antipsychotics like olanzapine or quetiapine, some antidepressants like mirtazapine or paroxetine, beta blockers like atenolol or metoprolol, and insulin or sulfonylureas for type 2 diabetes. The Mayo Clinic keeps a patient reference list of medications that cause weight gain.
Do not stop any of these on your own. The right move is to tell the Sunlight care team what other medications you are taking. A licensed clinician can flag any that might matter. Sometimes the doctor for your other condition can switch you to a weight-neutral option. Sometimes not. The point is that the combination needs to be visible to the clinician reviewing your GLP-1 plan.
7. An underlying condition is in the way
Four conditions show up often enough to mention: an underactive thyroid (TSH above 4 to 5 mIU/L), polycystic ovary syndrome (PCOS), insulin resistance and prediabetes, and Cushing’s syndrome (rarer, but worth flagging). Each of these can blunt or offset the weight loss that semaglutide-driven appetite reduction would otherwise produce.
According to the Mayo Clinic, low thyroid hormone slows your resting metabolism. That means a real semaglutide-driven appetite drop can produce less scale movement than expected. If you have not had recent labs (TSH, fasting glucose, A1c), the Sunlight care team can flag whether ordering them makes sense. A licensed clinician can review the results and adjust your plan.
PCOS specifically: semaglutide still works for many PCOS patients. But the pace may need to be calibrated, and metformin combinations are sometimes added by the prescribing clinician.
8. You may be a low responder
This is an important category that often goes undiscussed. About 10 to 15 percent of people on full-dose semaglutide are clinical low responders. That means they lose less than 5 percent of body weight after six months at the full dose (based on follow-up analyses of the Wilding group). This is a real biological category, not a moral one.
The signal pattern looks like this: you have been at 1.7mg or 2.4mg for at least 12 weeks. Your diet is in a real calorie deficit (logged or estimated). Your sleep is decent. No obvious medication interference. The scale still has not moved more than a few percent. At that point, the right conversation is not “try harder.” It is whether to switch medications.
Compounded tirzepatide works through a different pathway (it hits both GIP and GLP-1 receptors). It produced larger absolute weight loss than semaglutide in the SURMOUNT-5 trial of FDA-approved tirzepatide head-to-head against FDA-approved semaglutide (Aronne et al., NEJM 2025). That doesn’t mean every patient should switch — and it depends on dose history, side effect profile, and cost. The Sunlight care team can flag a switch conversation to a licensed clinician. The wrong move is to stay stuck on a medication that is not working for your body.
What to do this week if you're not losing weight on semaglutide
What to do this week — three steps, in order:
- Check the calendar and the dose. If you are under 12 weeks in and below 1.0mg, the right move is usually time, not panic. Mark week 12 on the calendar and revisit then.
- Message the Sunlight care team through the patient portal. Tell them your current dose, how many weeks you have been at it, what side effects you have had, what you have lost so far, and any other medications you are on. A licensed clinician can review your plan and adjust the dose ladder if appropriate. A real dose conversation beats another month of guessing.
- Hold off on a big diet overhaul until after that conversation. Most people at week 4 do not need a stricter diet. They need the right dose.
Already a Sunlight patient? Message the care team through the patient portal. Thinking about compounded semaglutide for the first time? Sunlight’s GLP-1 program starts at $179 for the first month. After that, standard month-to-month billing is $209. Six-month and 12-month plans cost less per month. Every plan includes the consult, monitoring, the compounded medication, and shipping. Take the eligibility quiz to see if a licensed clinician can prescribe semaglutide for you.
Important safety information
GLP-1 medications like semaglutide and tirzepatide can cause nausea, vomiting, diarrhea, constipation, or stomach pain. This is most common in the first weeks of treatment. Less common but serious risks include pancreatitis, gallbladder problems, and kidney injury if you get dehydrated. Thyroid C-cell tumors have been seen in rodent studies of GLP-1 drugs. These medications should not be used by patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). GLP-1 medications are not recommended during pregnancy or breastfeeding. Dosing is set by a licensed clinician. Do not self-adjust. Sunlight’s compounded semaglutide is prepared by a licensed compounding pharmacy and is not FDA-approved. Individual results may vary. If you have severe or lasting side effects, contact the Sunlight care team at 1-877-378-7008. Side effects can also be reported to the FDA at MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Frequently asked questions
How long does it take to lose weight on semaglutide?
Is it normal to not lose weight in the first 4 weeks on semaglutide?
Should I increase my semaglutide dose if I'm not losing weight?
Can you build a tolerance to semaglutide?
What percentage of people don't respond to semaglutide?
Should I switch from semaglutide to tirzepatide if it isn't working?
References
- Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity” (STEP-1). New England Journal of Medicine. 2021;384:989-1002.
- Aronne LJ, Horn DB, le Roux CW, et al. “Tirzepatide as Compared with Semaglutide for the Treatment of Obesity” (SURMOUNT-5). New England Journal of Medicine. May 2025.
- Mayo Clinic. “GLP-1 agonists: Diabetes drugs and weight loss.”
- Harvard Health Publishing. “Sleep and weight gain: What’s the connection?”
- U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” 2026.